Mount Sinai Heart Clinical Trials

• Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision (CONNECT) Study >
• The Cardiac Benefit of Androgen Replacement in Hypogonadal Males with Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI)-IV >
• Cobalt chromium Stent with Antiproliferative for Restenosis II Trial >
• A Prospective , Single Blind, Randomized, Multi-Center, Study Comparing the Cypher-ELITE to Cypher Bx VELOCITY Sirolimus-Eluting Stent Systems (ELITE Study) >
• Genetic Determinants of Peripheral Arterial Determinants of Disease >
• Warfarin vs. Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) >
• SKS Pilot Study: A Randomized Pilot Trial for Treatment of True Bifurcation Lesions with Simultaneous Kissing Stents (Conventional stent Vs SKS Technique). >
• A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, Slow-Release Formulation in the Treatment of High Risk De Novo Coronary Lesions (TAXUS V Trial) >
• A Phase II Randomized, double Blind, Placebo Controlled Study of the Effects of VIA-2291, a 5-Lipoxygenase Inhibitor, on Vascular Inflammation in subjects after an Acute Coronary Syndrome Event >
• IMPELLA RECOVER LP 2.5 System Study >
• ACS Study >
• CARE (Visipaque 320 and Isovue-370 in Cardiac Angiography in REnally Impaired Patients); FOLLOW-UP STUDY >
• Ambulatory Closure Device Percutaneous Intervention:a Multi-Center Randomized Trial Evaluating the Patient Satisfaction, Safety, and Cost-Effectiveness of Ambulatory PCI in the Current Era >
• Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel Disease- FREEDOM Trial-III/IV >
• CORAL Study >
• PACEmaker and Beta-blocker Therapy after Myocardial Infarction (The PACE-MI) Trial >
• A Prospective Feasibility Trial Investigating the use of the IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI >
• A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Risk PCI >
• Phase IV Warfarin vs Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) >
• The Cardiac Benefit of Androgen Replacement in Hypogonadal Males with Coronary Artery Disease Following Successful Percutaneous Coronary Intervention (PCI) >
• Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT). An Imaging Study in Patients with Unstable Atherosclerotic Lesions. >
• Coronary Computed Tomography for Systemic Triage of Acute Chest Pain Patients to Treatment (CT-STAT) >
• A Prospective, multi-center, randomized controlled trial of the IMPELLA RECOVER LP 2.5 System versus Intra Aortic Balloon Pump (IABP) in Patients Undergoing Non Emergent High Rick PCI >
• Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel Disease- FREEDOM Trial >
• A Clinical Trial comparing cangrelor to clopidogrel in subjects who require percutaneous coronary intervention >
• Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM Trial)-I >
• Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel Disease- FREEDOM Trial >
• A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Dose-Selection Study of Ad2/Hypoxia Inducible Factor (HIF)-1a/VP16 in Patients with Intermittent Claudication >
• A Randomized Pilot Trial for Aggressive Therapeutic Approaches in Aspirin Resistant Patients Undergoing Percutaneous Coronary Intervention (ASPIRIN-RESIST Trial) >
• A Randomized, Double-blind, Parallel Group, Phase III, Efficacy and Safety Study of AZD6140 Compared for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS).  >